Top compounds associated with response to NOMO1


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.086 0.01
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.089 0.01
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.087 0.01
mRNA bendamustine CTRPv2 pan-cancer AAC -0.092 0.02
mRNA NVP-ADW742 CTRPv2 pan-cancer AAC 0.085 0.02
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.084 0.02
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.02
mRNA YK 4-279 CTRPv2 pan-cancer AAC -0.076 0.02
mRNA CAY10618 CTRPv2 pan-cancer AAC -0.082 0.02
mRNA CD-437 CTRPv2 pan-cancer AAC -0.076 0.02
Download CSV